Sotagliflozin: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 May 2024

9 May 2024

  • curprev 23:5923:59, 9 May 2024‎ Alen Antony talk contribs‎ 1,667 bytes +19‎ No edit summary
  • curprev 15:1715:17, 9 May 2024‎ Alen Antony talk contribs‎ 1,648 bytes +1,230‎ No edit summary
  • curprev 04:5704:57, 9 May 2024‎ Alen Antony talk contribs‎ 418 bytes +418‎ Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=sotagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=prophylaxis |indication=heart failure in patients with risk of heart failure, type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors. |adverseReactions=urinary tract infection, volume depletion, diarrhea, and hypoglycemia. }}"
Retrieved from "https://www.wikidoc.org/index.php/Sotagliflozin"